Sylvain Jereme M 4

4 · DEXCOM INC · Filed Mar 10, 2026

AI-generated summary of this filing

Updated Mar 10, 2026

DexCom (DXCM) CFO Sylvain Jereme Receives RSU Award

What Happened

Sylvain Jereme, EVP and Chief Financial Officer of DexCom, was granted 48,774 restricted stock units (RSUs) on March 8, 2026 (grant reported on Form 4). On the same date, 18,950 shares were withheld to satisfy tax withholding obligations at an effective withholding price of $68.10 per share, totaling $1,290,495. The RSUs were granted at $0.00 (typical for RSUs) and vest in three equal annual installments.

Key Details

Transaction date: 2026-03-08; filing date: 2026-03-10 (timely).
Grant: 48,774 RSUs (code A) — RSUs are a contingent right to receive one share each upon vesting.
Tax withholding: 18,950 shares withheld (code F) at $68.10/share = $1,290,495; this withholding is to cover tax obligations and does not represent an open-market sale by the reporting person.
Shares owned after transaction: not specified in the filing.
Notable footnotes: RSUs are exempt under Section 16b-3 and vest in three equal annual installments (footnote F1). Footnote F3 indicates the reporting person has 92,794 unvested RSUs in total (including the 48,774 granted Mar 8, 2026) plus 261 shares from the ESPP.

Context

RSU grants are compensation awards and typically indicate retention/incentive arrangements rather than a market-direction bet. The withholding of shares to cover taxes (net settlement) is a routine administrative step and should not be read as a sell signal.

Form 4

Period: 2026-03-08

EVP, Chief Financal Officer

Transactions

Award
Common Stock
[F1]
2026-03-08+48,774→ 172,242 total
Tax Payment
Common Stock
[F2][F3]
2026-03-08$68.10/sh−18,950$1,290,495→ 153,292 total

Footnotes (3)

[F1]Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock.
[F2]Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person.
[F3]Included in this number are 92,794 unvested RSUs, 48,774 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 23,937 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 8,684 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 261 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan.

Signature

/s/ Jereme M. Sylvain|2026-03-10

1 file